Autres langues Emcure Pharmaceuticals Limited

Actions

EMCURE

INE168P01015

Produits pharmaceutiques

Cours en clôture NSE India S.E. 23/09/2026			Varia. 5j.	Varia. 1 janv.
1 981,70 ^INR	+0,34%		+2,58%	+45,23%

23/09	Emcure Pharmaceuticals Limited approuve un dividende final au titre de l’exercice clos le 31 mars 2026	CI
16/09	Gilead Sciences étend ses accords de licence pour son traitement contre le VIH	MT

Autres langues

23/09	Emcure Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended March 31, 2026
16/09	Gilead Sciences Expands Licensing Agreements for HIV Treatment
06/08	Emcure Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026
06/08	Emcure Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
06/08	Emcure Pharmaceuticals Limited Announces Board and Management Changes
21/07	Emcure Pharmaceuticals Limited Announces Cessation of P.S. Jayakumar as Independent Director and from Board Committees, Effective July 21, 2026
21/07	Emcure Pharmaceuticals Limited completed the acquisition of an additional unknown minority stake in Gennova Biopharmaceuticals Ltd. from Sanjay Singh.
20/07	Emcure Pharmaceuticals Limited Expands Use Of Poviztra For MASH Indication Following CDSCO Approval
13/07	Emcure Pharmaceuticals Limited executed a share transfer agreement to acquire an additional unknown minority stake in Gennova Biopharmaceuticals Ltd. from its shareholders.
13/07	Emcure Pharmaceuticals Limited executed a share transfer agreement to acquire an additional unknown minority stake in Gennova Biopharmaceuticals Ltd. from Sanjay Singh.
03/07	Emcure Pharmaceuticals Unit to Acquire Remaining Shares in Canada's Mantra Pharma for C$50 Million
30/06	Emcure Pharmaceuticals Limited Announces Superannuation of Kuber Jagdale from President ? API Business, Effective June 30, 2026
06/05	Emcure Pharmaceuticals Scouts for M&As
05/05	Emcure Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
05/05	Emcure Pharmaceuticals March-quarter consol net profit 2.43 billion rupees
04/05	Mauritius' BC Investments offloads shares in Indian drug maker Emcure
07/04	Apollo Tyres Ltd. Announces Resignation of Berjis Desai as Independent Director, Effective April 7, 2026
02/03	Emcure Pharmaceuticals and Roche sign distribution agreement in India
02/03	Emcure Pharmaceuticals Limited and Roche Sign Distribution Agreement to Strengthen Nephrology and Transplant Care in India
09/02	Emcure Pharma Reports Fire Incident at Pune Manufacturing Plant
04/02	Emcure Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
04/02	Emcure Pharmaceuticals Dec-quarter Consol Net Profit 2.31 Billion Rupees
04/02	Emcure Pharmaceuticals Limited Appoints Amruta Jana Yangalwar as Company Secretary and Compliance Officer, Effective February 4, 2026
31/01	Delhivery Limited Announces Board Changes
29/01	Emcure Pharmaceuticals Witnesses a Growth Spurt